Eyevance Pharmaceuticals has launched Zerviate, a treatment for ocular itching related to allergic conjunctivitis, in the United States, according to a press release.
Zerviate (cetirizine ophthalmic solution 0.24%) is formulated with the vehicle Hydrella, which contains glycerin and hydroxypropyl methylcellulose. These are common in tear lubricants and help to comfortably deliver the cetirizine molecule, the release said.
“Eyevance is building its core business around the commercialization of standout anterior segment and ocular surface products,” Jerry St. Peter, CEO, director and
Uncategorized